Attached files

file filename
8-K - FORM 8-K - InvenSense Incd287614d8k.htm

Exhibit 99.1

LOGO

INVENSENSE® ANNOUNCES THIRD QUARTER RESULTS

 

   

Third Quarter of Fiscal 2012 Net Revenues: $41.2 Million

 

   

Third Quarter of Fiscal 2012 Net Income: $10.6 Million

SUNNYVALE, California, January 26, 2012InvenSense, Inc. (NYSE: INVN), the leading provider of MotionTracking™ devices for consumer electronics, today announced quarterly results for the quarter ended January 1, 2012. For the third fiscal quarter of 2012, net revenue was $41.2 million, up 52 percent from the third quarter of fiscal 2011. Net revenue for the first nine months of 2012 was $119.9 million, up 65 percent from $72.7 million for the same period in 2011.

Net income for the third quarter of fiscal 2012 was $10.6 million, compared with net income of $4.7 million in the third quarter of fiscal 2011, an increase of 124 percent. For the first nine months of fiscal 2012, net income was $31.1 million, an increase of 357 percent over $6.8 million during the same period in 2011. Diluted earnings per share attributable to common stockholders* and diluted pro forma earnings per share** for the third quarter of fiscal 2012 was $0.10 per share and $0.13 per share, respectively, compared to $0.05 per share and $0.06 per share, respectively, for the same period of 2011.

Cash flow from operating activities during the first nine months of 2012 was $33.6 million, up 586 percent compared with cash flow from operating activities of $4.9 million during the same period in the prior fiscal year. InvenSense ended the quarter with $139.6 million in cash and cash equivalents and short-term investments.

Management Qualitative Comments

“This was an exciting quarter for InvenSense and all of its employees and shareholders, with our initial public offering on the New York Stock Exchange,” said Steven Nasiri, CEO, Chairman, and Founder, “We had strong revenue growth, despite a difficult global economic environment. We met our target profitability, reporting net income as a percentage of our net revenue of 26%. During our fiscal third quarter, we marked two significant milestones: first, we announced the World’s Smallest Dual-Axis Gyroscopes for Optical Image Stabilization in SmartPhones, and second, we began revenue shipments of our integrated 6-axis MPU-6050 products. Additionally, we introduced the World’s First Integrated 9 -Axis MotionTracking Device in early January, solidifying our technology leadership for motion-interface in the consumer electronics market.”

 

* Diluted net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders, calculated as net income less income allocable to the rights of Series A, Series B and Series C convertible preferred stock holders for the period prior to their conversion upon our initial public offering, by the weighted average number of common shares outstanding, including unvested restricted stock, and potential dilutive common shares assuming the dilutive effect of outstanding stock options using the treasury stock method.
** Pro forma diluted net income per share was computed to give effect to the conversion of the Series A, Series B, and Series C convertible preferred shares and certain preferred stock warrants both using the as-if converted method into common shares as if the conversion had occurred as of the beginning of each period presented.


Third Quarter Earnings Conference Call

A conference call will be held today at 1:30 p.m. Pacific Time to discuss the quarter’s results and management’s current business outlook. To listen to the conference call, please dial (866) 730-5763 ten minutes prior to the start of the call, using the passcode 70308100. International callers, please dial (857) 350-1587. A taped replay will be made available approximately two hours after the conclusion of the call and will remain available for one week. To access the replay, please dial (888) 286-8010 and enter passcode 75750370. International callers please dial (617) 801-6888. The conference call will also be available via a live webcast on the investor relations section of InvenSense’s web site at http://www.invensense.com. An archived webcast replay will be available on the web site for three months.

Forward-Looking Statements

Statements in this press release that are not historical are “forward-looking statements” as the term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally written in the future tense and/or preceded by words such as “will,” “expects,” “anticipates,” or other words that imply or predict a future state. Forward-looking statements include any projection of revenue, gross margin, expense or other financial items discussed in the Business Outlook section of this press release, including potential future sales of our newly announced and introduced products and the potential for the continued technology leadership of MotionTracking™ devices in providing motion-tracking solutions in the consumer electronics. Investors are cautioned that all forward-looking statements in this release involve risks and uncertainty that can cause actual results to differ from those currently anticipated, due to a number of factors, including without limitation, the continued adoption of motion tracking and motion sensing as an interface in consumer electronics products, our achievement of design wins, consumer acceptance of our customers’ products that incorporate our solutions, intense competition in our industry; our dependence on a limited number of customers for a substantial portion of our revenues; our lack of long-term supply contracts and dependence on limited sources of supply; our ability to continue to develop and introduce new and enhanced products on a timely basis; and potential decreases in average selling prices for our products, as well as changes in economic conditions in our markets and other risk factors discussed in documents filed by us with the Securities and Exchange Commission (SEC) from time to time. Copies of InvenSense’s SEC filings are posted on the company’s website and are available from the company without charge. Forward-looking statements are made as of the date of this release, and, except as required by law, the company does not undertake an obligation to update its forward-looking statements to reflect future events or circumstances.


About InvenSense

InvenSense (NYSE: INVN) is the leading provider of MotionTracking™ devices for the consumer electronics market. The company’s patented and patent-pending MotionFusion™ technology and Nasiri-Fabrication™ platform address the emerging needs of many mass-market consumer applications including smart phones, tablets, gaming devices, optical image stabilization, and remote controls for smart TVs, that require improved performance, enhanced features, and new and more intuitive motion and gesture-based motion-interface solutions. InvenSense is headquartered in Sunnyvale, California. More information can be found at http://www.invensense.com.

For Investor Inquiries, Contact:

Alan Krock

Chief Financial Officer

ir@invensense.com

For Press Inquiries, Contact:

David Almoslino

408.988.7339 x285

dalmoslino@invensense.com

© 2012 InvenSense, Inc. All rights reserved. InvenSense, MotionTracking, MotionProcessing, MotionProcessor, Nasiri-Fabrication, MotionFusion, MotionApps, DMP, and the InvenSense logo are trademarks of InvenSense, Inc. Other company and product names may be trademarks of the respective companies with which they are associated.


INVENSENSE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(In thousands, except per share amounts)

 

     Three Months Ended     Nine Months Ended  
     January 1,
2012
    December 26,
2010
    January 1,
2012
     December 26,
2010
 

Net revenue

   $ 41,229      $ 27,170      $ 119,890       $ 72,695   

Cost of revenue

     18,538        11,827        52,919         33,014   
  

 

 

   

 

 

   

 

 

    

 

 

 

Gross profit

     22,691        15,343        66,971         39,681   

Operating expenses:

         

Research and development

     4,758        3,792        14,099         11,380   

Selling, general and administrative

     4,427        4,863        12,836         11,478   
  

 

 

   

 

 

   

 

 

    

 

 

 

Total operating expenses

     9,185        8,655        26,935         22,858   
  

 

 

   

 

 

   

 

 

    

 

 

 

Income from operations

     13,506        6,688        40,036         16,823   

Other income (expense):

         

Change in fair value of warrant liabilities

     —          —          —           (4,025

Other income (expense), net

     (43     (16     166         (1
  

 

 

   

 

 

   

 

 

    

 

 

 

Other income (expense) — net

     (43     (16     166         (4,026
  

 

 

   

 

 

   

 

 

    

 

 

 

Income before income taxes

     13,463        6,672        40,202         12,797   

Income tax provision

     2,887        1,955        9,147         5,998   
  

 

 

   

 

 

   

 

 

    

 

 

 

Net income

     10,576        4,717        31,055         6,799   

Net income allocable to preferred stockholders

     5,157        3,684        20,618         5,631   
  

 

 

   

 

 

   

 

 

    

 

 

 

Net income attributable to common stockholders

   $ 5,419      $ 1,033      $ 10,437       $ 1,168   
  

 

 

   

 

 

   

 

 

    

 

 

 

Basic

   $ 0.11      $ 0.06      $ 0.36       $ 0.07   
  

 

 

   

 

 

   

 

 

    

 

 

 

Diluted

   $ 0.10      $ 0.05      $ 0.34       $ 0.06   
  

 

 

   

 

 

   

 

 

    

 

 

 

Weighted average shares outstanding in computing net income per share attributable to common stockholders:

         

Basic

     49,890        17,815        28,770         17,575   
  

 

 

   

 

 

   

 

 

    

 

 

 

Diluted

     55,294        22,281        33,591         22,144   
  

 

 

   

 

 

   

 

 

    

 

 

 

Pro forma net income per share of common stock:

         

Basic

   $ 0.14      $ 0.07      $ 0.44       $ 0.10   
  

 

 

   

 

 

   

 

 

    

 

 

 

Diluted

   $ 0.13      $ 0.06      $ 0.40       $ 0.09   
  

 

 

   

 

 

   

 

 

    

 

 

 

Weighted average shares outstanding pro forma:

         

Basic

     74,541        68,126        70,976         67,886   
  

 

 

   

 

 

   

 

 

    

 

 

 

Diluted

     80,416        74,143        76,696         74,021   
  

 

 

   

 

 

   

 

 

    

 

 

 
Supplemental Information - stock-based compensation expenses included in:   

Cost of revenue

   $ 78      $ 71      $ 237       $ 203   

Research and development

     349        235        995         693   

Selling, general and administrative

     474        238        1,275         676   
  

 

 

   

 

 

   

 

 

    

 

 

 

Total employee stock-based compensation expense

   $ 901      $ 544      $ 2,507       $ 1,572   
  

 

 

   

 

 

   

 

 

    

 

 

 


INVENSENSE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except par value)

 

     January 1,
2012
     April 3,
2011
 

Assets

     

Current assets:

     

Cash and cash equivalents

   $ 130,127       $ 28,795   

Short-term investments

     9,516         9,280   

Accounts receivable

     10,245         9,765   

Inventories

     16,059         15,208   

Prepaid expenses and other current assets

     2,930         2,249   
  

 

 

    

 

 

 

Total current assets

     168,877         65,297   

Property and equipment, net

     3,912         3,492   

Restricted time deposit

     188         194   

Other assets

     3,135         1,763   
  

 

 

    

 

 

 

Total assets

   $ 176,112       $ 70,746   
  

 

 

    

 

 

 

Liabilities and Stockholders’ Equity

     

Current liabilities:

     

Accounts payable

   $ 4,594       $ 6,687   

Accrued liabilities

     6,944         4,307   

Long-term debt — current portion

     27         18   
  

 

 

    

 

 

 

Total current liabilities

     11,565         11,012   

Long-term debt

     29         16   

Other long-term liabilities

     2,690         577   
  

 

 

    

 

 

 

Total liabilities

     14,284         11,605   

Commitments and contingencies

     

Stockholders’ equity:

     

Convertible preferred stock:

     

Series A convertible preferred stock, $0.001 par value — no shares issued and outstanding at January 1, 2012, 8,060 shares authorized and 8,000 shares issued and outstanding (aggregate liquidation value of $8,000) at April 3, 2011

     —           9,019   

Series B convertible preferred stock, $0.001 par value — no shares issued and outstanding at January 1, 2012, 6,566 shares authorized and 5,920 shares issued and outstanding (aggregate liquidation value of $11,000) at April 3, 2011

     —           22,341   

Series C convertible preferred stock, $0.001 par value — no shares issued and outstanding at January 1, 2012, 15,510 shares authorized and 15,510 shares issued and outstanding (aggregate liquidation value of $19,000), at April 3, 2011

     —           18,881   

Common stock, $0.001 par value — 750,000 shares authorized; 79,441 shares issued and outstanding at January 1, 2012, 18,005 shares issued and outstanding at April 3, 2011

     127,631         5,762   

Accumulated other comprehensive income

     5         1   

Retained earnings

     34,192         3,137   
  

 

 

    

 

 

 

Total stockholders’ equity

     161,828         59,141   
  

 

 

    

 

 

 

Total liabilities and stockholders’ equity

   $ 176,112       $ 70,746   
  

 

 

    

 

 

 


INVENSENSE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

     Nine Months Ended  
     January 1,
2012
    December 26,
2010
 

Cash flows from operating activities:

    

Net income

   $ 31,055      $ 6,799   

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     1,465        1,329   

Loss (gain) on disposal of property and equipment

     (160     74   

Stock-based compensation expense

     2,507        1,642   

Change in fair value of warrant liability

     —          4,025   

Deferred income tax assets

     175        393   

Write-off of deferred offering costs

     —          1,388   

Changes in operating assets and liabilities:

    

Accounts receivable

     (536     (4,661

Inventories

     (851     (6,571

Prepaid expenses and other current assets

     (585     341   

Other assets

     (1,603     (358

Accounts payable

     (2,297     (1,707

Accrued liabilities

     4,393        2,215   

Advances from customer

     —          (16
  

 

 

   

 

 

 

Net cash provided by operating activities

     33,563        4,893   
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Purchase of property and equipment

     (1,669     (2,001

Proceeds from the sale of property and equipment

     188        —     

Sale of available for sale investments

     7,793        141   

Purchase of available for sale investments

     (8,025     (5,233

Changes in restricted time deposits

     —          (88
  

 

 

   

 

 

 

Net cash used in investing activities

     (1,713     (7,181

Cash flows from financing activities:

    

Proceeds from initial public offering, net of underwriting commissions

     69,750        —     

Net proceeds from issuance of preferred stock

     499        —     

Proceeds from issuance of common stock

     969        582   

Offering costs

     —          (1,388

Proceeds from long-term debt and capital lease obligations

     —          43   

Payments of long-term debt and capital lease obligations

     (19     (353

Payments of IPO expenses

     (1,717     —     

Refund from refundable customer advances

     —          (4,000
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     69,482        (5,116
  

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     101,332        (7,404

Cash and cash equivalents:

    

Beginning of period

   $ 28,795      $ 22,394   
  

 

 

   

 

 

 

End of period

   $ 130,127      $ 14,990   

Supplemental disclosures of cash flow information:

    

Cash paid for interest

   $ 22      $ 16   
  

 

 

   

 

 

 

Cash paid for income taxes

   $ 6,586      $ 6,235   
  

 

 

   

 

 

 

Noncash investing and financing activities:

    

Unpaid accounts payable for property and equipment purchased

   $ 204      $ 261   
  

 

 

   

 

 

 

Unrealized gain (loss) from available for sale investments

   $ 5      $ 24   
  

 

 

   

 

 

 

Fixed assets acquired under capital leases

   $ 40      $ 43   
  

 

 

   

 

 

 

Unpaid deferred offering costs

   $ 357      $ 21   
  

 

 

   

 

 

 

Reclassification of warrants from liabilities to equity

   $ —        $ 11,877